Gansulin includes Gansulin N, Gansulin R, and premixed insulin. The generic name of Glycopyrrolin N is Low-Arginine Recombinant Human Insulin Injection and the generic name of Glycopyrrolin R is Recombinant Human Insulin Injection. Patients who do not have contraindications to this medication and who can tolerate the adverse effects of the medication are allowed to take it for a long period of time. Recombinant human insulin injection, low-arginine recombinant human insulin, and premixed insulin can be used for the treatment of diabetes mellitus; they are contraindicated in people who are allergic to recombinant human insulin. Adverse reactions such as hypoglycemia, temporary edema, adipose tissue hyperplasia, subcutaneous fat atrophy or sclerosis, etc., may occur after the use of the drug. If diabetic patients without the above contraindications do not see significant adverse effects after use or can tolerate the adverse effects can be long-term use of this class of drugs treatment. Patients who need to use recombinant human insulin injection, low-arginine recombinant human insulin treatment are recommended to use the drug under the guidance of a doctor.